BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Efficacy of Gynodian® Depot in Women With Impaired Well-being
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-20
- Last Posted Date
- 2014-12-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 140
- Registration Number
- NCT00463450
Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- Bayer
- Target Recruit Count
- 420
- Registration Number
- NCT00461305
Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 104
- Registration Number
- NCT00461396
FDA Phase IV - Commitment - Retinal Function Study
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2015-03-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 63
- Registration Number
- NCT00461565
Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-17
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 50
- Registration Number
- NCT00461123
A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-12
- Last Posted Date
- 2014-06-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 64
- Registration Number
- NCT00459654
BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-12
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1420
- Registration Number
- NCT00459667
An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2015-10-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 75
- Registration Number
- NCT00454558
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2014-09-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 460
- Registration Number
- NCT00453349
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 904
- Registration Number
- NCT00449033
© Copyright 2024. All Rights Reserved by MedPath